New hope for devastating virus: cord blood transplant trial seeks to control rare blood disorders
NCT ID NCT07381738
Summary
This study is testing whether a transplant using umbilical cord blood from an unrelated donor can effectively treat severe diseases caused by the Epstein-Barr virus (EBV). The trial will enroll 80 participants with specific EBV-related conditions that have not responded to standard treatments. Researchers aim to see if this transplant can control the disease and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huadong hospital, Fudan university
RECRUITINGShanghai, Shanghai Municipality, 200040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Huashan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200040, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.